Clinical Trial Update: Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating megestrol acetate in combination with rosuvastatin in young women with early endometrial cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• Megestrol acetate (megestrol acetate)
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Fudan University | Conditions: Endometrial Carcinoma Stage I | Phase 2 | Status: COMPLETED